Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move.
Here’s a look at the top five short squeeze candidates based on the Fintel short squeeze leaderboard.
Greenwich LifeSciences: Clinical stage biopharmaceutical company Greenwich LifeSciences GLSI moved back up to the top of the Fintel short squeeze leaderboard after ranking third last week. Data showed 28.5% of the float short, up from last week’s 27.5% reported. The cost to borrow on shares is 11.1%, down slightly from last week’s 11.6% reported.
Aerovate Therapeutics: Clinical stage biopharmaceutical company Aerovate Therapeutics AVTE jumped 18 places on the leaderboard to rank second for the week. Data showed 31.5% of the float short, the highest rate of the top five short-squeeze candidates. The cost to borrow on shares is 6.8%.
HeartBeam Inc: Heart attack detection technology company HeartBeam Inc BEAT made the biggest jump on the leaderboard, moving up 968 positions to third place. Data shows 11.7% of the float short. While the short percentage was the lowest of the top five short squeeze candidates, the cost to borrow will likely jump out to investors. Fintel reported a cost to borrow of 397.8%, one of the highest for the week.
Minerva Neurosciences: Clinical stage biopharmaceutical company Minerva Neurosciences Inc NERV ranked fourth on the short squeeze leaderboard, in line with last week’s ranking. Data showed 12.2% of the float short, down from last week’s reported 23.2%. The cost to borrow on shares is 79.7%. The company previously topped the short squeeze leaderboard in September.
Virgin Orbit Holdings: Satellite launch and space technology company Virgin Orbit Holdings Inc VORB jumped 38 places to rank fifth on the short squeeze leaderboard. Data showed 18.1% of the float short and a cost to borrow of 95.8%. The company, which went public via SPAC merger has shares currently near a 52-week low of $2.50 versus a 52-week high of $11.28.
Related Link: Tesla Tops Auto Stocks For Short Sellers, How Do Ford, Nio, Lucid And Rivian Rank?
Photo: gguy via Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.